Pretax income is the income that a company earns before paying income taxes. Unity Biotechnology's pretax income for the
three
months ended in Dec. 2024 was $-8.44 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was $-25.99 Mil.
Unity Biotechnology's pretax margin was %.
During the past 9 years, Unity Biotechnology's highest Pretax Margin was -1269.34%. The lowest was -18842.80%. And the median was -3231.26%.
Unity Biotechnology Pre-Tax Income Historical Data
The historical data trend for Unity Biotechnology's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Unity Biotechnology's Pre-Tax Income
For the Biotechnology subindustry, Unity Biotechnology's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Unity Biotechnology's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Unity Biotechnology's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Unity Biotechnology's Pre-Tax Income falls into.
Unity Biotechnology Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Unity Biotechnology's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-25.99 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Unity Biotechnology (NAS:UBX) Pre-Tax Income Explanation
Unity Biotechnology's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as
During the past 9 years, Unity Biotechnology's highest Pretax Margin was -1269.34%. The lowest was -18842.80%. And the median was -3231.26%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Unity Biotechnology Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Unity Biotechnology's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
UBX has been successfully added to your 